Defining the differences between episodic migraine and chronic migraine

Current Pain and Headache Reports

Volumn 16, Issue 1, 2012, Pages 86-92

  Katsarava, Zaza ^a   Buse, Dawn C ^b   Manack, Aubrey N ^c   Lipton, Richard B ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c ALLERGAN INC   (United States)

Author keywords

Chronic daily headache; Chronic migraine; Chronification; Diagnosis; Epidemiological profiles; Episodic migraine; Risk factors; Sociodemographics; Treatment

Indexed keywords

ANALGESIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERGOT DERIVATIVE; FLUOXETINE; GABAPENTIN; MEMANTINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREGABALIN; TIZANIDINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; VALPROIC ACID; ZONISAMIDE;

CHRONIC DAILY HEADACHE; COMORBIDITY; DEPRESSION; DISEASE COURSE; EPISODIC MIGRAINE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; LIFE EVENT; MEDICAL LEAVE; MIGRAINE; OBESITY; PAIN ASSESSMENT; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK FACTOR; SOCIOECONOMICS; TRANSFORMED MIGRAINE; TREATMENT RESPONSE; UNEMPLOYMENT; WORK DISABILITY;

CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; QUALITY OF LIFE; RECURRENCE; RISK FACTORS;

EID: 84857639723     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-011-0233-z     Document Type: Review

References (46)

1. World Health Organization. Headache disorders. Fact sheet N°277. http://www.who.int/mediacentre/factsheets/fs277/en/. 2004.
2. LJ Stovner K Hagen R Jensen Z Katsarava R Lipton A Scher T Steiner JA Zwart 2007 The global burden of headache: a documentation of headache prevalence and disability worldwide Cephalalgia 27 193 210 17381554 10.1111/j.1468-2982. 2007.01288.x (Pubitemid 46354128)
3. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24 Suppl 1:9-160.
4. J Olesen MG Bousser HC Diener D Dodick M First PJ Goadsby H Gobel MJ Lainez JW Lance RB Lipton G Nappi F Sakai J Schoenen SD Silberstein TJ Steiner 2006 New appendix criteria open for a broader concept of chronic migraine Cephalalgia 26 742 746 16686915 1:STN:280:DC%2BD283mt1Gruw%3D%3D 10.1111/j.1468-2982.2006.01172.x
5. ME Bigal D Serrano D Buse A Scher WF Stewart RB Lipton 2008 Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study Headache 48 1157 1168 18808500 10.1111/j.1526-4610.2008.01217.x
6. A Manack DC Buse D Serrano CC Turkel RB Lipton 2011 Rates, predictors, and consequences of remission from chronic migraine to episodic migraine Neurology 76 711 718 21270413 1:STN:280:DC%2BC3M3gslOhtA%3D%3D 10.1212/WNL.0b013e31820d8af2
7. •• Blumenfeld A, Varon S, Wilcox TK, Buse D, Kawata AK, Manack A, Goadsby PJ, Lipton RB: Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS). Cephalalgia 2011, 31:301-315. This is the only international (nine countries) study of migraine epidemiology. A web-based survey was used to compare those with episodic migraine to those with chronic migraine on headache features, headache-related disability, health-related quality of life, health care resource utilization, and medical and psychiatric comorbidities.
8. •• Buse DC, Manack A, Serrano D, Turkel C, Lipton RB: Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 2010, 81:428-432.This population-based study from the United States demonstrates that those with chronic migraine were significantly more likely to have a lower socioeconomic status and more psychiatric/medical comorbidities than those with episodic migraine.
9. ME Bigal D Serrano M Reed RB Lipton 2008 Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment Neurology 71 559 566 18711108 10.1212/01.wnl.0000323925.29520.e7
10. •• Katsarava Z, Manack A, Yoon M-S, Obermann M, Becker H, Dommes P, Turkel C, Lipton RB, Diener HC: Chronic migraine: Classification and comparisons. Cephalalgia 2011, published on January 10, 2011 as doi: 10.1177/0333102410383590. This epidemiologic study of a random population in Germany used three different definitions of chronic migraine and demonstrated that the epidemiological profiles of the three groups were similar but differ significantly from those with high- or low-frequency episodic migraine. The prevalence of chronic migraine also differed depending on the definition used.
11. RB Lipton ME Bigal M Diamond F Freitag ML Reed WF Stewart 2007 Migraine prevalence, disease burden, and the need for preventive therapy Neurology 68 343 349 17261680 1:STN:280:DC%2BD2s%2FlslCgsg%3D%3D 10.1212/01.wnl.0000252808. 97649.21 (Pubitemid 46184209)
12. Reed ML, Buse DC, Manack AN, Fanning KM, Serrano D, Turkel CC, Lipton RB: Prevalence of chronic migraine (CM), headache-related disability and sociodemographic factors in the US population: Results from the American Migraine Prevalence and Prevention (AMPP) study. Headache 2011, 51:28 [abstract P58].
13. • Natoli J, Manack A, Dean B, Butler Q, Turkel C, Stovner L, Lipton R: Global prevalence of chronic migraine: a systematic review. Cephalalgia 2010, 30:599-609. This review article describes the population prevalence of chronic migraine across different populations and explores the various diagnostic criteria for chronic migraine.
14. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 8 Suppl 7:1-96.
15. Silberstein SD, Lipton RB, Solomon S, Mathew N: Classification of daily and near-daily headaches in the headache clinic. Proposed revisions to the International Headache Society criteria. In Frontiers in Headache Research. Edited by Olesen J. New York: Raven Press, Ltd; 1994:117-126.
16. SD Silberstein RB Lipton M Sliwinski 1996 Classification of daily and near-daily headaches: field trial of revised IHS criteria Neurology 47 871 875 8857711 1:STN:280:DyaK2s%2FhtVKkug%3D%3D
17. ME Bigal S Ashina R Burstein ML Reed D Buse D Serrano RB Lipton 2008 Prevalence and characteristics of allodynia in headache sufferers: a population study Neurology 70 1525 1533 18427069 1:STN:280:DC%2BD1c3mvVGmtQ%3D%3D 10.1212/01.wnl.0000310645.31020.b1 (Pubitemid 351589506)
18. DW Dodick CC Turkel R DeGryse SK Aurora SD Silberstein RB Lipton HC Diener MF Brin 2010 on behalf of the PREEMPT Chronic Migraine Study Group: OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program Headache 50 921 936 20487038 10.1111/j.1526-4610.2010.01678.x
19. Buse DC, Manack AN, Serrano D, Varon SF, Turkel CC, Lipton RB: Headache impact of chronic and episodic migraine: Predictors of impact from the American Migraine Prevalence and Prevention (AMPP) study. Headache 2011, in press.
20. WF Stewart GC Wood A Manack SF Varon DC Buse RB Lipton 2010 Employment and Work Impact of Chronic Migraine and Episodic Migraine J Occup. Environ. Med 52 8 14 20042889 10.1097/JOM.0b013e3181c1dc56
21. J Munakata E Hazard D Serrano D Klingman MF Rupnow J Tierce M Reed RB Lipton 2009 Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) study Headache 49 498 508 19245386 10.1111/j.1526-4610.2009.01369.x
22. M Stokes WJ Becker RB Lipton SD Sullivan TK Wilcox L Wells A Manack I Proskorovsky J Gladstone DC Buse SF Varon PJ Goadsby AM Blumenfeld 2011 Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS) Headache 51 1058 1077 21762134 10.1111/j.1526-4610.2011.01945.x
23. K Kroenke RL Spitzer JB Williams 2001 The PHQ-9: validity of a brief depression severity measure J Gen. Intern. Med 16 606 613 11556941 1:STN:280:DC%2BD3MrhtVWnsQ%3D%3D 10.1046/j.1525-1497.2001.016009606.x (Pubitemid 32823891)
24. ME Bigal RB Lipton 2008 Concepts and mechanisms of migraine chronification Headache 48 7 15 18184280 10.1111/j.1526-4610.2007.00969.x
25. ME Bigal RB Lipton 2006 Modifiable risk factors for migraine progression Headache 46 1334 1343 17040331 10.1111/j.1526-4610.2006.00577.x (Pubitemid 44556426)
26. RB Lipton 2009 Tracing transformation: chronic migraine classification, progression, and epidemiology Neurology 72 S3 S7 19188564 10.1212/WNL. 0b013e3181974b19
27. ME Bigal RB Lipton 2006 Obesity is a risk factor for transformed migraine but not chronic tension-type headache Neurology 67 252 257 16864817 10.1212/01.wnl.0000225052.35019.f9 (Pubitemid 44305408)
28. N Breslau RB Lipton WF Stewart LR Schultz KM Welch 2003 Comorbidity of migraine and depression: investigating potential etiology and prognosis Neurology 60 1308 1312 12707434 1:STN:280:DC%2BD3s7ovVKhsQ%3D%3D (Pubitemid 36460987)
29. Ashina S, Serrano D, Lipton RB, Maizels M, Manack AN, Turkel CC, Reed ML, Buse DC: Depression is a risk factor for the transformation of episodic to chronic migraine. Cephalalgia 2011, under review.
30. BB Vargas DW Dodick 2009 The face of chronic migraine: epidemiology, demographics, and treatment strategies Neurol Clin 27 467 479 19289226 10.1016/j.ncl.2009.01.001
31. GE Tietjen BL Peterlin JL Brandes F Hafeez S Hutchinson VT Martin RM Dafer SK Aurora MR Stein NA Herial C Utley L White SA Khuder 2007 Depression and anxiety: effect on the migraine-obesity relationship Headache 47 866 875 17578537 10.1111/j.1526-4610.2007.00810.x (Pubitemid 46944388)
32. AI Scher WF Stewart D Buse DS Krantz RB Lipton 2008 Major life changes before and after the onset of chronic daily headache: a population-based study Cephalalgia 28 868 876 18557980 1:STN:280:DC%2BD1cvnslKrsw%3D%3D 10.1111/j.1468-2982.2008.01634.x
33. HC Diener V Limmroth 2004 Medication-overuse headache: a worldwide problem Lancet Neurol 3 475 483 15261608 10.1016/S1474-4422(04)00824-5 (Pubitemid 38903098)
34. Z Katsarava S Schneeweiss T Kurth U Kroener G Fritsche A Eikermann HC Diener V Limmroth 2004 Incidence and predictors for chronicity of headache in patients with episodic migraine Neurology 62 788 790 15007133 1:STN:280:DC%2BD2c7hslektw%3D%3D (Pubitemid 38298959)
35. JA Zwart G Dyb K Hagen S Svebak J Holmen 2003 Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study Neurology 61 160 164 12874392 (Pubitemid 36875294)
36. SJ Wang JL Fuh SR Lu CY Liu LC Hsu PN Wang HC Liu 2000 Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up Neurology 54 314 319 10668689 1:STN:280:DC%2BD3c7jt1WhsQ%3D%3D
37. SR Lu JL Fuh WT Chen KD Juang SJ Wang 2001 Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors Cephalalgia 21 980 986 11843870 1:STN:280:DC%2BD387isVeluw%3D%3D 10.1046/j.1468-2982.2001.00294.x (Pubitemid 34626035)
38. AI Scher WF Stewart RB Lipton 2004 Caffeine as a risk factor for chronic daily headache: a population-based study Neurology 63 2022 2027 15596744 1:CAS:528:DC%2BD2MXjvFWquw%3D%3D (Pubitemid 39636246)
39. PJ Goadsby T Sprenger 2010 Current practice and future directions in the prevention and acute management of migraine Lancet Neurol 9 285 298 20170842 10.1016/S1474-4422(10)70005-3
40. • Lipton RB, Chu MK: Conceptualizing the relationship between chronic migraine and episodic migraine. Expert Rev Neurother. 2009, 9:1451-1454. This is the first editorial to describe that chronic migraine and episodic migraine are distinct but intimately related disorders.
41. HC Diener G Bussone JC Van Oene M Lahaye S Schwalen PJ Goadsby 2007 Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study Cephalalgia 27 814 823 17441971 10.1111/j.1468-2982.2007.01326.x (Pubitemid 46961730)
42. SD Silberstein RB Lipton DW Dodick FG Freitag N Ramadan N Mathew JL Brandes M Bigal J Saper S Ascher DM Jordan SJ Greenberg J Hulihan 2007 Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial Headache 47 170 180 17300356 10.1111/j.1526-4610.2006.00684.x
43. M Naumann Y So CE Argoff MK Childers DD Dykstra GS Gronseth B Jabbari HC Kaufmann B Schurch SD Silberstein DM Simpson 2008 Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology 70 1707 1714 18458231 1:CAS:528:DC%2BD1cXnsFGgtrk%3D 10.1212/01.wnl.0000311390.87642.d8 (Pubitemid 351644139)
44. SK Aurora DW Dodick CC Turkel R DeGryse SD Silberstein RB Lipton HC Diener MF Brin on behalf of PREEMPT 1 Chronic Study Group 2010 OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized placebo-controlled phase of the PREEMPT 1 trial Cephalalgia 30 793 803 20647170 1:STN:280:DC%2BC3cjgt1Sjtg%3D%3D 10.1177/0333102410364676
45. HC Diener DW Dodick SK Aurora CC Turkel R DeGryse RB Lipton SD Silberstein MF Brin on behalf of the PREEMPT 2 Chronic Migraine Study Group 2010 OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial Cephalalgia 30 804 814 20647171 1:STN:280:DC%2BC3cjgt1Sjtw%3D%3D 10.1177/0333102410364677
46. HC Diener D Holle D Dodick 2010 Treatment of chronic migraine Curr Pain Headache Rep 15 64 69 10.1007/s11916-010-0159-x